The Truth about Peptides

About this event

It’s hard to open a social media site these days without hearing about “peptides.” Although many known drugs are peptides (like insulin or thyroid), this term typically refers to a set of experimental compounds purporting to do everything from healing injuries to increasing longevity. Recent actions by the FDA’s Pharmacy Compounding Advisory Committee (PCAC) put these drugs in an even greater spotlight as the committee recommended that 7 peptides be recategorized to allow them to be compounded and made available to patients. We will discuss what these compounds are, their current legal status, and whether the literature supports the PCAC’s recommendation. WHO: Peter Koshland, PharmD, is a graduate of Georgetown University (Chemistry BS) and the University of California at San Francisco School of Pharmacy (PharmD). He has served as an Adjunct Clinical Professor of Pharmacy at UCSF since 2010. He is the CEO and Founder of Koshland Pharm, which is a custom compounding pharmacy in the San Francisco Bay region. It is the only compounding pharmacy accredited by the Pharmacy Compounding Accreditation Board. In addition to leading Koshland Pharm, Dr. Koshland trains and consults with doctors across the state of California in the areas of hormone replacement, thyroid disorders, and compounding applications for dermatology, urology, pain management, and psychiatry. He was invited to speak at the National Academies of Sciences, Engineering and Medicine in 2019. He is a current Board Member and Chair-Elect of the Alliance for Pharmacy Compounding, a national organization representing pharmacists in both 503A and 503B pharmacies. WHEN: Thursday 8 October @ 7:30pm Pacific (GMT-7) HOW: Online HERE (https://www.youtube.com/watch?v=QN2X9TyVWYw). Join us! This is a free event brought to you by Bay Area Skeptics. All are welcome. Dr. Koshland will take your questions at the end of his presentation.